Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
Discover unmet pharmaceutical needs. Effectively prioritize market opportunities. Deliver optimal returns. Datamonitor Healthcare’s in-depth expert data analysis and robust interactive data tools meet your needs and address your challenges in an ever-changing market.
How it helps
The breadth of coverage ensures you can assess revenue potential and identify competitive threats, market catalysts, and untapped new product development opportunities more holistically than ever before.
How it works
Content created by a global team of award-winning specialist analysts, and an easy-to-use interface that streamlines information gathering make Datamonitor Healthcare the go-to solution for the pharmaceutical and biotechnology industries.
It offers:
Assess revenue potential, competitive threats, market catalysts, and untapped product development opportunities with most up-to-date, comprehensive coverage of drugs, companies, epidemiology, diseases, strategy, and pricing and reimbursement trends.
Gauge the relative strength of upcoming drugs with our drug comparator tool. Identify untapped opportunities with our state-of-the art, interactive forecasting tool, event-driven forecasts updated within 48 hours, and patient-based sales forecasts from surveys of more than 200 physicians per indication.
Our acclaimed Ask-the-Analyst™ service puts you in direct contact with our global analyst team. Our comprehensive and timely market reports help you understand macro trends and synthesize key insights to make data actionable.
Receive accurate replies to your queries in minutes, not hours with 24/7 live customer support. Stay up-to-speed on the latest market developments with customizable email alerts that notify you of updates to the information most important to you.
Datamonitor Healthcare
By Michael Haydock 26 Apr 2018
Mr. Haydock & Mr. Haas used the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.
Datamonitor Healthcare
15 Apr 2018
Zach McLellan, Jack Allen, and guest analyst Michael Ramirez discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the Novartis purchase of AveXis for $8.7 billion as they target gene therapy in SMA.
Topic Company analysis
Datamonitor Healthcare
By Jack Allen 09 Apr 2018
Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.
Datamonitor Healthcare, Biomedtracker
05 Apr 2018
To beat your competition, turn to the combined power of Biomedtracker and Datamonitor Healthcare for the most reliable and timely information in the industry.
Topic Drug review
Datamonitor Healthcare
By Jack Allen 20 Mar 2018
Zach McLellan, Jack Allen, and guest analysts Louisa Joseph and Michael Haydock discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including results for Gilead's new HIV flagship product; Biktarvy, and the US approval of the HIV drug Trogarzo, the first for salvage patients.
Datamonitor Healthcare
By Jack Allen 09 Mar 2018
Zach McLellan, Jack Allen, and guest analyst Dan Chancellor discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. Featuring analysis of the Sangamo Therapeutics and Gilead/Kite partnership for allogeneic oncology products & update on Restasis patent disputes.
Topic Company analysis
Datamonitor Healthcare
By Zachary McLellan 19 Feb 2018
Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including a recap of the 2018 BIO CEO conference, Phase IIb results of aramchol in HIV-lipodystrophy NAFLD or NASH patients, and the approval of Ereleada (apalutamide) in non-metastatic castration-resistant prostate cancer.
Datamonitor Healthcare
By Jack Allen 09 Feb 2018
Zach McLellan, Jack Allen, and this weeks guest analyst from London, Ines Mihel, discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a discussion around the announcement of "profit-free" health insurance plans from Amazon, JP Morgan, and Berkshire Hathaway.
Topic Drug approval
Datamonitor Healthcare
By Jack Allen 08 Feb 2018
Jack Allen, Senior Analyst, Cardiovascular and Metabolic, Datamonitor Healtcare, leads the webinar. Topics covered: Overview of the Dyslipidemia Market Treatment Options Pipeline Therapies in Development Prescribing Trends Dyslipidemia Forecast.
Topic Dyslipidaemia
Datamonitor Healthcare
22 Jan 2018
Zach McLellan, Jack Allen, and this weeks guest analyst Dustin Phan, discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a discussion of Celgene's potential acquisition of Juno.
Topic Cancer Clinical trials
Datamonitor Healthcare
07 Jan 2018
Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a roundtable discussion of potential deals prior to the JPM Healthcare Conference.
Topic Cancer
Datamonitor Healthcare
20 Dec 2017
Zach McLellan, Kevin Shannon and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast including Results from bluebird bio’s anti-BCMA CAR T.
Topic Cancer Clinical trials
Datamonitor Healthcare
05 Dec 2017
Zach McLellan, Kevin Shannon and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast including a CDK-4/6 inhibitors sales review and a Bluebird bio LentiGlobin ASH abstract review.
Topic Drug review
Datamonitor Healthcare
01 Dec 2017
Zach McLellan, Kevin Shannon and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast including Amgen migraine data and Bavencio Phase III gastric failure.
Topic Company analysis Drug review
Datamonitor Healthcare
18 Oct 2017
Its forecasted that Zilretta, will reach sales of $768m in the US
Topic FDA
USA
Rachel specializes in
+22 year(s) experience
Connecticut, USA
Amanda specializes in
+18 year(s) experience
USA
Michael specializes in
+18 year(s) experience
Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. Scrip is essential for anyone making commercial decisions in the pharmaceutical industry.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
Looking for more products Product Finder
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
